期刊文献+

二次电切加术中黏膜下注射吡柔比星治疗表浅性膀胱癌疗效分析 被引量:8

下载PDF
导出
摘要 目的对比二次电切加术中黏膜下膀胱注射吡柔比星与单次电切术后即刻灌注吡柔比星预防浅表膀胱癌复发的疗效。方法 47例表浅性膀胱癌患者随机分为观察组、对照组。观察组25例行2次电切手术,第二次在术中给予30mg吡柔比星膀胱黏膜下注射;对照组22例单次电切术后6h内给予30mg吡柔比星膀胱灌注。出院后3、6、12个月检查1次膀胱镜,1年后半年检查1次,观察两组间肿瘤复发率差异。结果随访17~35个月(平均24个月),观察组有4例(16.0%)肿瘤复发;对照组有7例(31.8%)肿瘤复发。所有患者未见明显全身药物不良反应。结论二次电切加术中黏膜下膀胱注射吡柔比星能显著降低膀胱癌患者术后复发率,其效果优于单次电切后即刻膀胱灌注。
出处 《现代泌尿外科杂志》 CAS 2013年第2期189-191,共3页 Journal of Modern Urology
  • 相关文献

参考文献13

  • 1SCHULZE M, STOTZ N, RASSWEILER J. Retrospective a- nalysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: in dications and efficacy of a differentiated apbroach[J]. J Endou ro,1 2007, 21(12): 1533-1541.
  • 2HAN KS,JOUNG JY,CHO KS,et al. Results of repeated tran surethral resection for a second opinion in patients referred for nonmuscle invasive bladder cancer:the referral cancer center ex perienee and review of the literature [J]. J Endourol, 2008, 22 (12):2699-2704.
  • 3李成龙,祝恒成.二次电切对T_1G_3期膀胱肿瘤疗效影响的回顾性分析[J].临床泌尿外科杂志,2011,26(10):745-746. 被引量:13
  • 4KRIEGMAIR M, ZAAK D, ROTHENBERGER KH, et al Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscpy [J]. J Urol,2002,168:475.
  • 5霍庆祥,孙建涛,张寒,张艺.非肌层浸润膀胱移形上皮癌二次电切术疗效分析及意义(附42例报告)[J].中国内镜杂志,2010,16(9):953-955. 被引量:7
  • 6OOSTERLINCK W,LOBEL B,JAKSE G,et al. European asso- ciation of urology(EAU) working group on oncological urology guidelines on bladder cancer[J]. Eur Urol, 2002,41: 105.
  • 7MAY M, BRAUN K P, RICHTER W, et al. Radical cystecto- my in the treatment of bladder cancer always in due time[J] Urologe A. 2007.46 : 913-919.
  • 8DIVRIK T, YILDIRIM U, EROGLU AS, et al. Is a second transurethral resection necessary fornewly diagnosed pT1 blad- der cancer[J]. J Urol,2006, 175 : 1258-1261.
  • 9GRINM MO, STEINHOFF C, SMION X, et al. Effect of rou tine repeat transurethral resection for superficial bladder cancer a long-term observational study[J]. Uorl, 2003,170(2ptl) : 433437.
  • 10SCHULZE M, STOTZ N, RASSWEILER J. Retrospective a- nalysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: in- dications and efficacy of a differentiated approach [J] J Endou- rol,2007,21(12) : 1533-1541.

二级参考文献31

  • 1张广健,吴长利,韩瑞发,赵玉干,马腾骧,王广有,王凡.膀胱肿瘤抗药机制的实验研究[J].中华泌尿外科杂志,1996,17(4):203-206. 被引量:26
  • 2万江华,靳风烁.膀胱肿瘤的再次电切[J].国际泌尿系统杂志,2006,26(6):756-759. 被引量:3
  • 3SCHWAIBOLD HE, SILVALINGAM S, MAY F, et al. The value of a second transurethral resection for T1 bladder cancer[J]. BJU Int 2006, 97(6): 1199-1201.
  • 4MALMSTROM PU, BUSCH C, NORLEN BJ. Recurrence, progression, and sur--ivat in bladder cancer [J]. Scand J Urol Nephrol, 1987, 21: 185-195.
  • 5MILADI M, PEYROMAURE M, ZERBIB M, et al. The value of a second transurethral resection on evaluating patients with bladder tumors [J]. Eu Ural, 2003, 43(3): 241-245.
  • 6KONETY BR, WILLIAMS RD. Superficial transitional (Ta/T1/CIS) cellcarcinoma of the bladder[J]. BJU Int, 2004, 94(1): 18-21.
  • 7HERR HW. The value of second transurethral resection in evaluating patients with bladder tumors[J]. J Urol, 1999, 162(1): 74-76.
  • 8MICHAEL A. Advances in the management of superficial bladder cancer[J]. Semin Oncol, 2007, 34(2): 85-97.
  • 9GRIMM MO, STEINHOFF C, SIMON X, et al. Effect of routine repeat transurethral resection of superficial bladder cancer: A long term observational study[JJ. J Urol, 2003, 170(2): 433-437.
  • 10BRAUSI M, COLLETTE L, KURTH K, et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta TI transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies[J]. Eur Urol, 2002, 41 (5): 523-527.

共引文献207

同被引文献59

  • 1王月生,江福能,何慧婵,韩兆冬,毕学成,钟惟德.膀胱癌发病与非酒精类饮料相关性分析[J].中华临床医师杂志(电子版),2011,5(7):2075-2077. 被引量:4
  • 2李法锦,施浩强,唐亮,张涛,樊松,江长琴,葛俊,王明丽,梁朝朝.人巨细胞病毒感染对围手术期尿路上皮癌患者免疫功能的影响[J].肿瘤防治研究,2014,41(2):119-123. 被引量:4
  • 3张国飞,吴越,王立,孙大炜,邓玮.经尿道汽化电切术治疗浅表性膀胱肿瘤42例[J].中国微创外科杂志,2007,7(9):915-916. 被引量:5
  • 4WorldHe.althOrganization. 2012 - 2 - 29 [ N/L]. http://www. who. int/mediacent re/fact sheet s/fs297/en/index, html.
  • 5于满.膀胱癌后发生肾盂和输尿管癌:发生率、危险因素和临床病理发现[J].国外医学.泌尿系统分册,1990,(3):137-138.
  • 6Vogel JU, Otte J, Koch F, et al. Role of human cytomegalovirus genotype polymorphisms in AIDS patients with cytomegalovirus ret- initis [ J ]. Medical Microbiology and Immunology, 2013 , 202 ( 1 ) : 3747.
  • 7Ma Y, Li M, Zheng B, etal. Overlapping transcription strueture of human cytomegalovirus UL140 and UL141 genes[ J]. J Biosci, 2013, 38(1) .3544.
  • 8Hinotsu S,Akaza H,Naito S,et al.Mainte- nance therapy with bacillus Calmette- Gu6rin Connaught strain clearly prolongs recurrence -free survival following transurethral resection of bladder tumour for non-muscle-invasive bladder cancer [J].BJU international, 2011,108 ( 2 ) : 187 -195.
  • 9O'Brien T,Ray E,Chatterton K,et al. Prospective randomized trial of hexy- laminolevulinate photodynamic -assisted transurethral resection of bladder tumour (TURBT)plus single-shot intravesieal mitomycin C vs conventional white-light TURBT plus mitomyein C in newly pre- senting non-musele-invasive bladder can- cer[J].BJU international, 2013, 112 (8) : 1096-104.
  • 10Vishnukamal Golla,Philip Levy Ho,Daniel L. Willis,Graciela Noguera-Gonzalez,Neema Navai,Ashish M. Kamat,Colin P.N. Dinney,J.B. Shah.MP50-20 ABSENCE OF TUMOR ON REPEAT TURBT DOES NOT PREDICT FINAL PATHOLOGIC T0 STAGE IN MUSCLE INVASIVE BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY[J]. The Journal of Urology . 2014 (4)

引证文献8

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部